IRIS
BUONERBA, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.538
NA - Nord America 3.126
EU - Europa 2.553
SA - Sud America 411
AF - Africa 118
OC - Oceania 7
Totale 9.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.982
SG - Singapore 1.481
RU - Federazione Russa 1.208
VN - Vietnam 859
CN - Cina 576
IT - Italia 372
BR - Brasile 303
DE - Germania 231
HK - Hong Kong 221
NL - Olanda 147
FR - Francia 124
FI - Finlandia 106
GB - Regno Unito 106
IN - India 100
JP - Giappone 67
CA - Canada 65
UA - Ucraina 53
MX - Messico 49
AR - Argentina 46
SE - Svezia 44
IE - Irlanda 41
CI - Costa d'Avorio 40
ZA - Sudafrica 33
KR - Corea 27
PL - Polonia 27
PH - Filippine 26
TH - Thailandia 26
BD - Bangladesh 25
AT - Austria 17
ES - Italia 17
IQ - Iraq 17
ID - Indonesia 16
PK - Pakistan 16
CZ - Repubblica Ceca 13
BE - Belgio 11
CL - Cile 11
EC - Ecuador 11
TR - Turchia 11
KE - Kenya 10
TW - Taiwan 10
CO - Colombia 9
VE - Venezuela 9
JO - Giordania 8
MA - Marocco 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
EG - Egitto 6
LT - Lituania 6
PE - Perù 6
PY - Paraguay 6
BO - Bolivia 5
IR - Iran 5
TN - Tunisia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
IL - Israele 4
KZ - Kazakistan 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SN - Senegal 4
AU - Australia 3
BG - Bulgaria 3
HN - Honduras 3
JM - Giamaica 3
LB - Libano 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
AL - Albania 2
BS - Bahamas 2
BZ - Belize 2
CH - Svizzera 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
LC - Santa Lucia 2
MD - Moldavia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
UY - Uruguay 2
AD - Andorra 1
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
CV - Capo Verde 1
DZ - Algeria 1
ET - Etiopia 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
Totale 9.737
Salva come PNG Salva come JPEG
Città #
Singapore 724
San Jose 556
Ashburn 307
Moscow 269
Ho Chi Minh City 233
Beijing 214
Chandler 207
Hong Kong 206
Hanoi 176
Amsterdam 124
Naples 116
Munich 112
Santa Clara 103
Los Angeles 102
Lauterbourg 70
The Dalles 65
Hefei 62
Millbury 59
New York 58
Tokyo 57
Dong Ket 56
Dallas 54
Boston 47
Da Nang 47
Turku 44
Council Bluffs 38
Lawrence 38
Buffalo 36
Napoli 34
Des Moines 33
Redondo Beach 31
Haiphong 30
Frankfurt am Main 28
Princeton 27
São Paulo 26
Helsinki 25
Orem 25
Warsaw 24
Seattle 23
Nanjing 22
Kochi 21
Wilmington 21
London 20
Brooklyn 19
Chicago 19
Houston 18
Mexico City 18
Nuremberg 17
Phoenix 17
Washington 17
Ottawa 16
Toronto 16
Denver 15
Dublin 15
Johannesburg 15
Atlanta 14
Chennai 13
Milan 13
Stockholm 13
Can Tho 12
Lappeenranta 12
Montreal 12
Rome 12
San Francisco 12
Seoul 12
Poplar 11
Rio de Janeiro 11
Shanghai 11
Baghdad 10
Bari 10
Biên Hòa 9
Charlotte 9
Nanchang 9
Bangkok 8
Buenos Aires 8
Changsha 8
Fairfield 8
Falkenstein 8
Hebei 8
Jacksonville 8
Tianjin 8
Vienna 8
Bến Tre 7
Curitiba 7
Düsseldorf 7
Guarulhos 7
Paris 7
Quezon City 7
Stuttgart 7
Tashkent 7
Thái Nguyên 7
Amman 6
Boardman 6
Brasília 6
Caserta 6
Hải Dương 6
Jakarta 6
Long Xuyen 6
Manchester 6
Memphis 6
Totale 5.166
Salva come PNG Salva come JPEG
Nome #
Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up 261
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 198
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis 186
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 171
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 169
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 166
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): A population-based study 163
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 160
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 157
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? 156
A third-line sorafenib aftrer sequential therapy with sunitinib and mTOR inhibitors in methastatic renal cell carcinoma 155
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 155
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 154
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 152
The use of chest ultrasonography in suspected cases of COVID-19 in the emergency department 150
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2 149
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 148
Combination of docetaxel and cetuximab for penile cancer: a case report and literature review 147
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 146
Biomarkers in localized prostate cancer 144
A comprehensive outlook on inracerebral therapy of malignant gliomas 142
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 142
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study 142
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 142
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 142
Liquid biopsy in bladder cancer: State of the art and future perspectives 141
The tnfrsf13c h159y variant is associated with severe covid-19: A retrospective study of 500 patients from southern italy 140
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 139
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 139
A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. 138
Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review 138
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone 137
Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients. 136
Lack of cumulative toxicity associated with cabazitaxel use in prostate cancer 135
Instant messaging in cancer care 132
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 131
Regulatory noncoding and predicted pathogenic coding variants of ccr5 predispose to severe covid-19 130
Castration-resistant prostate cancer: current and emerging treatment strategies 129
Locally advanced paranasal sinus carcinoma: A study of 30 patients 128
Preoperative Albumin-to-Alkaline Phosphatase Ratio as an Independent Predictor of Lymph Node Involvement in Penile Cancer 126
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review 126
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 126
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 125
The emerging role of obesity, diet and lipid metabolism in prostate cancer 124
Urologic malignancies: advances in the analysis and interpretation of clinical findings 123
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 123
Phase II Study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer 122
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 122
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database 121
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 120
Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung. 120
Imatinib mesylate in thymic epithelial malignancies. 120
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 120
Predicting pathological features at radical prostatectomy in patients with prostate cancer eligible for active surveillance by multiparametric magnetic resonance imaging 120
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 120
An adjusted indirect comparison of everolimus andsorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples 119
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 118
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. 117
COVID-19 and prostate cancer: A complex scenario with multiple facets 116
Rapidly progressive disease in a castration-resistant prostate cancer patient after cabazitaxel discontinuation 110
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 108
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 107
The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study 101
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities 100
Clinical significance of detectable blood lead and cadmium in the Sarno river basin population: results from the PREVES-STOP study 96
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy 96
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 95
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 94
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting 88
Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison. 87
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL 84
Current imaging evaluation of tumor response to advanced medical treatment in metastatic renal-cell carcinoma: Clinical implications 79
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients 74
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 62
Fascin-1 and its role as a serological marker in prostate cancer: A prospective case-control study 61
Serum copper, rubidium, selenium, strontium, and zinc and psychophysical health in adults of the Sarno river Basin: PREVES-STOP 2025 community biomonitoring results 33
Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy 32
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data 27
BLOSSOM Dietary Habits and 1-Year Intravesical Recurrence in High-Risk Non-Muscle-Invasive Bladder Cancer Treated with BCG 20
PEACE: Development and Validation of a Brief Five-Item Sleep Quality Scale for Community and Primary Care 9
Totale 9.881
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 0 72
2021/2022556 20 6 10 2 3 5 8 13 144 45 159 141
2022/2023611 66 25 33 15 73 62 8 63 100 112 46 8
2023/2024442 12 67 85 36 25 55 3 62 2 6 58 31
2024/20252.601 101 94 3 32 106 109 235 141 198 267 1.070 245
2025/20265.222 553 291 537 472 892 238 691 255 656 420 170 47
Totale 9.881